Definition:
Zelig Eshhar is a name associated with an individual, specifically an Israeli immunologist and researcher known for his contributions to the field of cancer immunotherapy.
Overview:
Zelig Eshhar is recognized for his pioneering work in the development of chimeric antigen receptor (CAR) T-cell therapy. This innovative approach involves genetically engineering a patient’s T cells to target and destroy cancer cells, particularly in hematological malignancies such as certain types of leukemia and lymphoma. His research has significantly influenced the advancement of adoptive immunotherapies and has laid foundational groundwork for current clinical applications of CAR T-cell treatments.
Etymology/Origin:
The name "Zelig" is of Yiddish and Hebrew origin, derived from the German word "selig," meaning "blessed" or "happy." "Eshhar" appears to be a Hebrew surname; however, its precise etymological roots or meaning are not widely documented in public linguistic sources.
Characteristics:
Zelig Eshhar is primarily known for:
- Pioneering the concept of CAR T-cell technology in the late 1980s and 1990s.
- Holding academic and research positions at the Weizmann Institute of Science in Israel.
- Receiving multiple scientific awards for his contributions to immunology and oncology.
- Collaborating with other leading researchers to advance the clinical implementation of engineered T cells.
Related Topics:
- CAR T-cell therapy
- Immunotherapy
- Cancer research
- T cell engineering
- Weizmann Institute of Science
- Adoptive cell transfer
Accurate information is based on publicly available scientific and institutional sources.